doi: 10.1161/hs1201.099652
(Stroke. 2001;32:2898.)
© 2001 American Heart Association, Inc.
Original Contributions |
Progression and Clinical Recurrence of Symptomatic Middle Cerebral Artery Stenosis
A Long-Term Follow-Up Transcranial Doppler Ultrasound Study
From the Cerebrovascular Unit, Department of Neurology, Hospital Vall d’Hebron, Barcelona, Spain.
Correspondence to Juan F. Arenillas, MD, Cerebrovascular Unit, Hospital Vall d’Hebron, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain. E-mail juanfarenillas{at}terra.es
Background and Purpose— Patients with symptomatic intracranial atherosclerotic stenosis have a high rate of recurrence. We conducted a prospective study to determine which factors are associated with the progression of symptomatic middle cerebral artery (MCA) stenosis and to evaluate the relationship between progression and clinical recurrence.
Methods— Between January 1996 and February 2000, of a total of 2564 consecutive first-ever transient ischemic attack (TIA) or stroke patients admitted to our cerebrovascular unit, 145 showed an MCA stenosis signal on transcranial Doppler (TCD) on admission, and 40 fulfilled all criteria to enter this study, including angiographic confirmation. Patients were prescribed antiplatelet or anticoagulant agents following the criteria of the neurologist in charge. TCD recordings and clinical interviews were performed regularly during follow-up. Progression of MCA stenosis was defined as an increase >30 cm/s in TCD-recorded maximum mean flow velocity. Logistic regression analyses were used to identify predictors of progression and clinical recurrence.
Results— With a median follow-up of 26.55 months, 13 (32.5%) MCA stenoses progressed, 3 (7.5%) regressed, and 24 (60%) remained stable. Absence of significant extracranial internal carotid artery (ICA) stenosis (P=0.049) and the use of oral anticoagulants (P=0.045) were significantly associated with a lower progression rate in univariate analysis, and anticoagulation remained an independent predictor when a logistic regression model was applied (OR 7.25, CI 1.1 to 48.1, P=0.019). A new ischemic event during follow-up in the territory supplied by the stenosed MCA occurred in 8 cases (20%), and 13 patients had a major vascular event. Progression of the MCA stenosis detected by TCD was independently associated with a new ipsilateral ischemic event (OR 2.89, CI 1.09 to 7.71, P=0.031) and with the occurrence of any major vascular event (OR 7.03, CI 1.6 to 30.9, P=0.0071).
Conclusions— Progression of symptomatic MCA stenosis detected by means of TCD predicts clinical recurrence. Anticoagulation is independently associated with a lower progression rate of symptomatic MCA stenosis.
Key Words: atherosclerosis • cerebral ischemia • middle cerebral artery • stenosis • ultrasonography, Doppler, transcranial
This article has been cited by other articles:
 |
|
 |
|
  J. F. Arenillas, J. Alvarez-Sabin, C. A. Molina, P. Chacon, I. Fernandez-Cadenas, M. Ribo, P. Delgado, M. Rubiera, A. Penalba, A. Rovira, et al. Progression of Symptomatic Intracranial Large Artery Atherosclerosis Is Associated With a Proinflammatory State and Impaired Fibrinolysis Stroke, May 1, 2008; 39(5): 1456 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Bos, P. J. Koudstaal, A. Hofman, J. C.M. Witteman, and M. M.B. Breteler Transcranial Doppler Hemodynamic Parameters and Risk of Stroke: The Rotterdam Study Stroke, September 1, 2007; 38(9): 2453 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-J. Jiang, B. Du, T. W. Leung, X.-T. Xu, M. Jin, and K.-H. Dong Symptomatic Intracranial Stenosis: Cerebrovascular Complications from Elective Stent Placement Radiology, April 1, 2007; 243(1): 188 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Liu, W. Li, and Z.-Q. Liu Middle Cerebral Artery Stenosis: Stenting Is One of the Options: Yes Stroke, April 1, 2007; 38(4): 1418 - 1419. [Full Text] [PDF]
|
|
|
|
 |
|
 D.-W. Kang, S. U. Kwon, S.-H. Yoo, K.-Y. Kwon, C. G. Choi, S. J. Kim, J.-Y. Koh, and J. S. Kim Early Recurrent Ischemic Lesions on Diffusion-Weighted Imaging in Symptomatic Intracranial Atherosclerosis Arch Neurol, January 1, 2007; 64(1): 50 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yoon, J. J. Seo, K. H. Cho, M. K. Kim, B. C. Kim, M. S. Park, T. S. Kim, J. K. Kim, and H. K. Kang Symptomatic Middle Cerebral Artery Stenosis Treated with Intracranial Angioplasty: Experience in 32 Patients Radiology, November 1, 2005; 237(2): 620 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kern, W. Steinke, M. Daffertshofer, R. Prager, and M. Hennerici Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease Neurology, September 27, 2005; 65(6): 859 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Arenillas, J. Candell-Riera, G. Romero-Farina, C. A. Molina, P. Chacon, S. Aguade-Bruix, J. Montaner, G. de Leon, J. Castell-Conesa, and J. Alvarez-Sabin Silent Myocardial Ischemia in Patients With Symptomatic Intracranial Atherosclerosis: Associated Factors Stroke, June 1, 2005; 36(6): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Tang, J.-S. Jeng, P.-K. Yip, C.-J. Lu, B.-S. Hwang, W.-H. Lin, and H.-M. Liu Transcranial Color-Coded Sonography for the Detection of Middle Cerebral Artery Stenosis J. Ultrasound Med., April 1, 2005; 24(4): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. U. Kwon, Y.-J. Cho, J.-S. Koo, H.-J. Bae, Y.-S. Lee, K.-S. Hong, J. H. Lee, and J. S. Kim Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis Stroke, April 1, 2005; 36(4): 782 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsumoto, T. Terada, M. Tsuura, H. Matsumoto, O. Masuo, H. Yamaga, and T. Itakura Diffusion-Weighted Imaging Abnormalities after Percutaneous Transluminal Angioplasty and Stenting for Intracranial Atherosclerotic Disease AJNR Am. J. Neuroradiol., February 1, 2005; 26(2): 385 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Arenillas, J. Alvarez-Sabin, J. Montaner, A. Rosell, C. A. Molina, A. Rovira, M. Ribo, E. Sanchez, and M. Quintana Angiogenesis in Symptomatic Intracranial Atherosclerosis: Predominance of the Inhibitor Endostatin Is Related to a Greater Extent and Risk of Recurrence Stroke, January 1, 2005; 36(1): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Kremer, T Schaettin, D Georgiadis, and R W Baumgartner Prognosis of asymptomatic stenosis of the middle cerebral artery J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1300 - 1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Arenillas, C. A. Molina, P. Chacon, A. Rovira, J. Montaner, P. Coscojuela, E. Sanchez, M. Quintana, and J. Alvarez-Sabin High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis Neurology, July 13, 2004; 63(1): 27 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Jiang, Y.-J. Wang, B. Du, S.-X. Wang, G.-H. Wang, M. Jin, and J.-P. Dai Stenting of Symptomatic M1 Stenosis of Middle Cerebral Artery: An Initial Experience of 40 Patients Stroke, June 1, 2004; 35(6): 1375 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Sloan, A. V. Alexandrov, C. H. Tegeler, M. P. Spencer, L. R. Caplan, E. Feldmann, L. R. Wechsler, D. W. Newell, C. R. Gomez, V. L. Babikian, et al. Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, May 11, 2004; 62(9): 1468 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Arenillas, J. Alvarez-Sabin, C. A. Molina, P. Chacon, J. Montaner, A. Rovira, B. Ibarra, and M. Quintana C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large-Artery Occlusive Disease Stroke, October 1, 2003; 34(10): 2463 - 2468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Haubrich, W. Kruska, R.R. Diehl, W. Moller-Hartmann, and C. Klotzsch Dynamic Autoregulation Testing in Patients With Middle Cerebral Artery Stenosis Stroke, August 1, 2003; 34(8): 1881 - 1885. [Abstract] [Full Text] [PDF]
|
|